{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:00:04Z","timestamp":1790254804605,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["R21DA058117-01A1"],"award-info":[{"award-number":["R21DA058117-01A1"]}]},{"name":"NIH","award":["R21DA058117-01A1"],"award-info":[{"award-number":["R21DA058117-01A1"]}]},{"name":"NIH","award":["R21DA058117-01A1"],"award-info":[{"award-number":["R21DA058117-01A1"]}]},{"name":"NIH","award":["R21DA058117-01A1"],"award-info":[{"award-number":["R21DA058117-01A1"]}]},{"name":"NIH","award":["R21DA058117-01A1"],"award-info":[{"award-number":["R21DA058117-01A1"]}]},{"name":"NIH","award":["R21DA058117-01A1"],"award-info":[{"award-number":["R21DA058117-01A1"]}]},{"name":"NIH","award":["R21DA058117-01A1"],"award-info":[{"award-number":["R21DA058117-01A1"]}]},{"name":"NIH","award":["R21DA058117-01A1"],"award-info":[{"award-number":["R21DA058117-01A1"]}]},{"name":"NIH","award":["R21DA058117-01A1"],"award-info":[{"award-number":["R21DA058117-01A1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Methadone is a highly effective treatment for opioid use disorder (OUD). Yet its impact is constrained by low rates of treatment initiation and retention, driven in part by geographic inequalities in the availability of methadone-providing opioid treatment programs (OTPs) and restrictions on the types of clinical settings where methadone can be dispensed. In response, in July 2021, the Drug Enforcement Administration released a new rule allowing OTPs to dispense medications for OUD\u2014including methadone\u2014through mobile medication units (MMU) without the need for additional treatment waivers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted interviews with 11 participants living in a residential substance use treatment facility in NYC and receiving methadone treatment (MT) from an MMU. Interview data were coded using Dedoose software based on a combination of inductive and deductive coding strategies, and guided by a thematic approach to explore patient\u2019s treatment experiences and perceptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants described MMU as substantially reducing the logistical burden of treatment while also allowing patients to avoid problems associated with brick-and-mortar OTPs. Some raised minor complaints (i.e., additional waiting time on medication delivery days), yet participants framed these concerns within the context of their overall preference for MMU. Participants also expressed uncertainty about how methadone treatment would continue after leaving residential care, highlighting potential challenges in transitioning from mobile services to traditional clinic settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our findings provide qualitative evidence from patients\u2019 perspectives on how mobile methadone delivery can potentially reshape the logistical demands, treatment environments, and continuity-of-care challenges associated with methadone treatment in residential settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13722-026-00692-0","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:05:21Z","timestamp":1782925521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cIt\u2019s so much easier for them to just come to us\u201d: a qualitative study examining the implementation of mobile methadone treatment serving a residential SUD treatment program"],"prefix":"10.1186","volume":"21","author":[{"given":"David","family":"Frank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristianny","family":"Ruelas-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"O\u2019Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashly E.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Saloner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"6960","key":"692_CR1","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/bmj.309.6960.997","volume":"309","author":"M Farrell","year":"1994","unstructured":"Farrell M, Ward J, Mattick R, Hall W, Stimson GV, Des Jarlais D, et al. Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review. BMJ. 1994;309(6960):997\u20131001.","journal-title":"BMJ"},{"issue":"5\u20136","key":"692_CR2","first-page":"347","volume":"67","author":"H Joseph","year":"2000","unstructured":"Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med. 2000;67(5\u20136):347\u201364.","journal-title":"Mt Sinai J Med"},{"issue":"3","key":"692_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5694\/j.1326-5377.1999.tb127675.x","volume":"170","author":"JR Caplehorn","year":"1999","unstructured":"Caplehorn JR, Drummer OH. Mortality associated with New South Wales methadone programs in 1994: lives lost and saved. Med J Aust. 1999;170(3):104\u20139.","journal-title":"Med J Aust"},{"issue":"2","key":"692_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/10826089609045806","volume":"31","author":"JR Caplehorn","year":"1996","unstructured":"Caplehorn JR, Dalton MS, Haldar F, Petrenas A-M, Nisbet JG. Methadone maintenance and addicts\u2019 risk of fatal heroin overdose. Subst Use Misuse. 1996;31(2):177\u201396.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"692_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","volume":"103","author":"A Gibson","year":"2008","unstructured":"Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O\u2019Brien S. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction. 2008;103(3):462\u20138.","journal-title":"Addiction"},{"issue":"1","key":"692_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0740-5472(03)00031-X","volume":"25","author":"G Gerra","year":"2003","unstructured":"Gerra G, Ferri M, Polidori E, Santoro G, Zaimovic A, Sternieri E. Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables. J Subst Abuse Treat. 2003;25(1):1\u20138.","journal-title":"J Subst Abuse Treat"},{"key":"692_CR7","unstructured":"Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. Springer Science & Business Media; 2012."},{"issue":"11","key":"692_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamapsychiatry.2020.1511","volume":"77","author":"PJ Joudrey","year":"2020","unstructured":"Joudrey PJ, Edelman EJ, Wang EA. Methadone for opioid use disorder\u2014decades of effectiveness but still miles away in the US. JAMA psychiatry. 2020;77(11):1105\u20136.","journal-title":"JAMA psychiatry"},{"issue":"13","key":"692_CR9","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/jama.2019.12562","volume":"322","author":"PJ Joudrey","year":"2019","unstructured":"Joudrey PJ, Edelman EJ, Wang EA. Drive times to opioid treatment programs in urban and rural counties in 5 US states. JAMA. 2019;322(13):1310\u20132.","journal-title":"JAMA"},{"key":"692_CR10","doi-asserted-by":"publisher","first-page":"107968","DOI":"10.1016\/j.drugalcdep.2020.107968","volume":"211","author":"PJ Joudrey","year":"2020","unstructured":"Joudrey PJ, Chadi N, Roy P, Morford KL, Bach P, Kimmel S, et al. Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: a cross-sectional study. Drug Alcohol Depend. 2020;211:107968.","journal-title":"Drug Alcohol Depend"},{"key":"692_CR11","doi-asserted-by":"publisher","first-page":"108329","DOI":"10.1016\/j.jsat.2021.108329","volume":"126","author":"N Krawczyk","year":"2021","unstructured":"Krawczyk N, Williams AR, Saloner B, Cerd\u00e1 M. Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings. J Subst Abuse Treat. 2021;126:108329.","journal-title":"J Subst Abuse Treat"},{"key":"692_CR12","doi-asserted-by":"crossref","unstructured":"Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerd\u00e1 M. Has the treatment gap for opioid use disorder narrowed in the US? A yearly assessment from 2010 to 2019. Int J Drug Policy. 2022;111:103786.","DOI":"10.1016\/j.drugpo.2022.103786"},{"issue":"1","key":"692_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1472-6963-14-281","volume":"14","author":"CR May","year":"2014","unstructured":"May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, MacDonald S, et al. Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Serv Res. 2014;14(1):281.","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"692_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.jclinepi.2012.05.005","volume":"65","author":"ND Shippee","year":"2012","unstructured":"Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012;65(10):1041\u201351.","journal-title":"J Clin Epidemiol"},{"key":"692_CR15","doi-asserted-by":"publisher","first-page":"209428","DOI":"10.1016\/j.josat.2024.209428","volume":"164","author":"MT Davis","year":"2024","unstructured":"Davis MT, Tschampl C, Hodgkin D, Regis C, Taveras E, Plant B, et al. Mobile clinics for opioid use disorders: What they do and how they do it. A qualitative analysis. J Subst use Addict Treat. 2024;164:209428.","journal-title":"J Subst use Addict Treat"},{"issue":"3","key":"692_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jamapsychiatry.2021.3716","volume":"79","author":"JB Gibbons","year":"2022","unstructured":"Gibbons JB, Stuart EA, Saloner B. Methadone on wheels\u2014a new option to expand access to care through mobile units. JAMA psychiatry. 2022;79(3):187\u20138.","journal-title":"JAMA psychiatry"},{"issue":"5","key":"692_CR17","doi-asserted-by":"publisher","first-page":"e14271","DOI":"10.1111\/1475-6773.14271","volume":"59","author":"JB Gibbons","year":"2024","unstructured":"Gibbons JB, Li W, Stuart EA, Saloner B. Simulated impact of mobile opioid treatment program units on increasing access to methadone for opioid use disorder. Health Serv Res. 2024;59(5):e14271.","journal-title":"Health Serv Res"},{"issue":"7\u20138","key":"692_CR18","first-page":"8","volume":"14","author":"S Ali","year":"2017","unstructured":"Ali S, Tahir B, Jabeen S, Malik M. Methadone treatment of opiate addiction: a systematic review of comparative studies. Innovations Clin Neurosci. 2017;14(7\u20138):8.","journal-title":"Innovations Clin Neurosci"},{"key":"692_CR19","unstructured":"Agency; DE. Registration requirements for narcotic treatment programs with mobile components. In: Justice; USDo, editor. 2021."},{"key":"692_CR20","unstructured":"Nguyen R, Staatz C, Vine M. Implementation of mobile medication units: findings from a qualitative study. Prepared for the Office of the Assistant Secretary for Planning and Evaluation (ASPE) at the U.S. Department of Health & Human Services. 2025."},{"key":"692_CR21","volume-title":"Mobile Medication Units Guidance for Opioid Treatment Programs","author":"(OASAS) NYSOoASaS","year":"2022","unstructured":"(OASAS) NYSOoASaS. Mobile Medication Units Guidance for Opioid Treatment Programs. Albany, NY: OASAS; 2022."},{"issue":"2","key":"692_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0376-8716(96)01273-2","volume":"42","author":"L Greenfield","year":"1996","unstructured":"Greenfield L, Brady JV, Besteman KJ, De Smet A. Patient retention in mobile and fixed-site methadone maintenance treatment. Drug Alcohol Depend. 1996;42(2):125\u201331.","journal-title":"Drug Alcohol Depend"},{"key":"692_CR23","doi-asserted-by":"publisher","first-page":"108483","DOI":"10.1016\/j.jsat.2021.108483","volume":"129","author":"B Chan","year":"2021","unstructured":"Chan B, Hoffman KA, Bougatsos C, Grusing S, Chou R, McCarty D. Mobile methadone medication units: a brief history, scoping review and research opportunity. J Subst Abuse Treat. 2021;129:108483.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"692_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","volume":"46","author":"G Hall","year":"2014","unstructured":"Hall G, Neighbors CJ, Iheoma J, Dauber S, Adams M, Culleton R, et al. Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals. J Subst Abuse Treat. 2014;46(4):511\u20135.","journal-title":"J Subst Abuse Treat"},{"key":"692_CR25","doi-asserted-by":"publisher","first-page":"1407522","DOI":"10.3389\/fpubh.2024.1407522","volume":"12","author":"A Pinkhover","year":"2024","unstructured":"Pinkhover A, Celata K, Baker T, Chatterjee A, Lunze K. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit. Front public health. 2024;12:1407522.","journal-title":"Front public health"},{"issue":"6","key":"692_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/MEG.0000000000000843","volume":"29","author":"MJ Silva","year":"2017","unstructured":"Silva MJ, Pereira C, Loureiro R, Balsa C, Lopes P, \u00c1gua-Doce I, et al. Hepatitis C in a mobile low-threshold methadone program. Eur J Gastroenterol Hepatol. 2017;29(6):657\u201362.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"692_CR27","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1360-0443.1990.tb01598.x","volume":"85","author":"EC Buning","year":"1990","unstructured":"Buning EC, van Brussel GH, van Santen G. The \u2018methadone by bus\u2019 project in Amsterdam. Br J Addict. 1990;85(10):1247\u201350.","journal-title":"Br J Addict"},{"issue":"7","key":"692_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0706743717711167","volume":"62","author":"JK Eibl","year":"2017","unstructured":"Eibl JK, Morin K, Leinonen E, Marsh DC. The state of opioid agonist therapy in Canada 20 years after federal oversight. Can J Psychiatry. 2017;62(7):444\u201350.","journal-title":"Can J Psychiatry"},{"issue":"6","key":"692_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2471\/BLT.20.251983","volume":"99","author":"R Rao","year":"2021","unstructured":"Rao R, Yadav D, Bhad R, Rajhans P. Mobile methadone dispensing in Delhi, India: implementation research. Bull World Health Organ. 2021;99(6):422.","journal-title":"Bull World Health Organ"},{"key":"692_CR30","unstructured":"Nicholas R. Opioid agonist therapy in Australia: a history. 2022."},{"issue":"1","key":"692_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-021-00535-y","volume":"18","author":"D Frank","year":"2021","unstructured":"Frank D, Mateu-Gelabert P, Perlman DC, Walters SM, Curran L, Guarino H. It\u2019s like \u2018liquid handcuffs: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients\u2019 lives. Harm Reduct J. 2021;18(1):1\u201310.","journal-title":"Harm Reduct J"},{"issue":"2","key":"692_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/10826084.2017.1310247","volume":"53","author":"D Frank","year":"2018","unstructured":"Frank D. I was not sick and I didn\u2019t need to recover: Methadone Maintenance Treatment (MMT) as a refuge from criminalization. Subst Use Misuse. 2018;53(2):311\u201322.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"692_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/poq\/nfm006","volume":"71","author":"PC Beatty","year":"2007","unstructured":"Beatty PC, Willis GB. Research synthesis: The practice of cognitive interviewing. Pub Opin Q. 2007;71(2):287\u2013311.","journal-title":"Pub Opin Q"},{"key":"692_CR34","doi-asserted-by":"publisher","first-page":"114523","DOI":"10.1016\/j.socscimed.2021.114523","volume":"292","author":"M Hennink","year":"2022","unstructured":"Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med. 2022;292:114523.","journal-title":"Soc Sci Med"},{"key":"692_CR35","doi-asserted-by":"crossref","unstructured":"Fusch PI, Ness LR. Are we there yet? Data saturation in qualitative research. 2015.","DOI":"10.46743\/2160-3715\/2015.2281"},{"key":"692_CR36","unstructured":"Dedoose. Version 9.0.107, cloud application for managing, analyzing, and presenting qualitative and mixed method research data (2023). 2025 [Available from: https:\/\/www.dedoose.com\/."},{"issue":"4","key":"692_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","volume":"11","author":"V Braun","year":"2019","unstructured":"Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qualitative research in sport. Exerc health. 2019;11(4):589\u201397.","journal-title":"Exerc health"},{"issue":"3","key":"692_CR38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","volume":"18","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qualitative Res Psychol. 2021;18(3):328\u201352.","journal-title":"Qualitative Res Psychol"},{"key":"692_CR39","doi-asserted-by":"crossref","unstructured":"Maguire M, Delahunt B. Doing a thematic analysis: a practical, step-by-step guide for learning and teaching scholars. All Irel J High Educ. 2017;9(3).","DOI":"10.62707\/aishej.v9i3.335"},{"key":"692_CR40","doi-asserted-by":"crossref","unstructured":"Lincoln YS, Guba EG. Naturalistic inquiry. Sage; 1985.","DOI":"10.1016\/0147-1767(85)90062-8"},{"key":"692_CR41","unstructured":"Shaller D. Patient-centered care: what does it take? Commonwealth Fund New York; 2007."},{"issue":"4","key":"692_CR42","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1077558712465774","volume":"70","author":"C Rathert","year":"2013","unstructured":"Rathert C, Wyrwich MD, Boren SA. Patient-centered care and outcomes: a systematic review of the literature. Med Care Res Rev. 2013;70(4):351\u201379.","journal-title":"Med Care Res Rev"},{"issue":"10","key":"692_CR43","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.socscimed.2010.08.008","volume":"71","author":"Y-Y Lee","year":"2010","unstructured":"Lee Y-Y, Lin JL. Do patient autonomy preferences matter? Linking patient-centered care to patient\u2013physician relationships and health outcomes. Soc Sci Med. 2010;71(10):1811\u20138.","journal-title":"Soc Sci Med"},{"issue":"3","key":"692_CR44","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1016\/S2468-2667(23)00023-3","volume":"8","author":"N Krawczyk","year":"2023","unstructured":"Krawczyk N, Rivera BD, Levin E, Dooling BC. Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy. Lancet Public Health. 2023;8(3):e238\u201346.","journal-title":"Lancet Public Health"},{"key":"692_CR45","doi-asserted-by":"publisher","first-page":"111283","DOI":"10.1016\/j.drugalcdep.2024.111283","volume":"258","author":"AE Jordan","year":"2024","unstructured":"Jordan AE, Bachhuber MA, Tuazon E, Jimenez C, Lincourt P, Hussain S, et al. Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations. Drug Alcohol Depend. 2024;258:111283.","journal-title":"Drug Alcohol Depend"},{"key":"692_CR46","doi-asserted-by":"publisher","first-page":"209547","DOI":"10.1016\/j.josat.2024.209547","volume":"168","author":"Y Bao","year":"2025","unstructured":"Bao Y, O\u2019Grady MA, Hutchings K, Hu JC, Campbell K, Knopf E, et al. Payment and billing strategies to support methadone take-home medication: Perspectives of financial leaders of opioid treatment program organizations in New York State. J Subst Use Addict Treat. 2025;168:209547.","journal-title":"J Subst Use Addict Treat"},{"issue":"4","key":"692_CR47","doi-asserted-by":"publisher","first-page":"e227028","DOI":"10.1001\/jamanetworkopen.2022.7028","volume":"5","author":"PJ Joudrey","year":"2022","unstructured":"Joudrey PJ, Kolak M, Lin Q, Paykin S, Anguiano V, Wang EA. Assessment of community-level vulnerability and access to medications for opioid use disorder. JAMA Netw Open. 2022;5(4):e227028\u2013e.","journal-title":"JAMA Netw Open"},{"key":"692_CR48","doi-asserted-by":"crossref","unstructured":"Suen LW, Incze M, Simon C, Englander H, Bratberg J, Groves Scott G, Winograd R. Methadone\u2019s resurgence in bridging the treatment gap in the overdose crisis: position statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction). Subst Use Addict J. 2024;45(3):29767342241255480.","DOI":"10.1177\/29767342241255480"},{"issue":"1","key":"692_CR49","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/08897077.2022.2060438","volume":"43","author":"LW Suen","year":"2022","unstructured":"Suen LW, Castellanos S, Joshi N, Satterwhite S, Knight KR. The idea is to help people achieve greater success and liberty: A qualitative study of expanded methadone take-home access in opioid use disorder treatment. Substance abuse. 2022;43(1):1143\u201350.","journal-title":"Substance abuse"},{"key":"692_CR50","doi-asserted-by":"crossref","unstructured":"Chinh B, Zade H, Ganji A, Aragon C, editors. Ways of qualitative coding: a case study of four strategies for resolving disagreements. Extended abstracts of the 2019 CHI conference on human factors in computing systems. 2019.","DOI":"10.1145\/3290607.3312879"},{"issue":"5","key":"692_CR51","doi-asserted-by":"publisher","first-page":"qxad061","DOI":"10.1093\/haschl\/qxad061","volume":"1","author":"PJ Joudrey","year":"2023","unstructured":"Joudrey PJ, Halpern D, Lin Q, Paykin S, Mair C, Kolak M. Methadone prescribing by addiction specialists likely to leave communities without available methadone treatment. Health affairs scholar. 2023;1(5):qxad061.","journal-title":"Health affairs scholar"},{"key":"692_CR52","unstructured":"Williams T. Opioid users are filling jails. Why don\u2019t jails treat them. New York Times. 2017."},{"key":"692_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/jurban\/jti072","volume":"82","author":"JD Rich","year":"2005","unstructured":"Rich JD, Boutwell AE, Shield DC, Key RG, McKenzie M, Clarke JG, Friedmann PD. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urb Health. 2005;82:411\u20139.","journal-title":"J Urb Health"},{"issue":"9","key":"692_CR54","doi-asserted-by":"publisher","first-page":"e2434704","DOI":"10.1001\/jamanetworkopen.2024.34704","volume":"7","author":"EF Balawajder","year":"2024","unstructured":"Balawajder EF, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, et al. Factors associated with the availability of medications for opioid use disorder in US jails. JAMA Netw open. 2024;7(9):e2434704\u2013e.","journal-title":"JAMA Netw open"},{"key":"692_CR55","unstructured":"NIH. Fewer than half of U.S. jails provide life-saving medications for opioid use disorder 2025 [Available from: https:\/\/www.nih.gov\/news-events\/news-releases\/fewer-half-us-jails-provide-life-saving-medications-opioid-use-disorder."},{"key":"692_CR56","doi-asserted-by":"crossref","unstructured":"Cotton BP, Bryson WC, Bruce ML. Methadone maintenance treatment for older adults: cost and logistical considerations. American Psychiatric Association Arlington, VA; 2018.","DOI":"10.1176\/appi.ps.201700137"},{"key":"692_CR57","doi-asserted-by":"crossref","unstructured":"Simon C, Vincent L, Coulter A, Salazar Z, Voyles N, Roberts L, et al. The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists. American Public Health Association; 2022. p. S117\u201322.","DOI":"10.2105\/AJPH.2021.306665"},{"key":"692_CR58","doi-asserted-by":"crossref","unstructured":"Krawczyk N, Bunting AM, Frank D, Arshonsky J, Gu Y, Friedman SR, Bragg MA. How will I get my next week\u2019s script? Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic. Int J Drug Policy. 2021;92:103140.","DOI":"10.1016\/j.drugpo.2021.103140"},{"key":"692_CR59","doi-asserted-by":"publisher","first-page":"209616","DOI":"10.1016\/j.josat.2024.209616","volume":"170","author":"D Frank","year":"2025","unstructured":"Frank D, Bennett AS, Cleland CM, Meyerson BE, Russell DM, Walters SM, et al. I still can feel the sickness: Withdrawal experiences of people on methadone maintenance treatment. J Subst Use Addict Treat. 2025;170:209616.","journal-title":"J Subst Use Addict Treat"},{"key":"692_CR60","doi-asserted-by":"publisher","first-page":"103803","DOI":"10.1016\/j.drugpo.2022.103803","volume":"110","author":"TJ Stopka","year":"2022","unstructured":"Stopka TJ, Rottapel RE, Ferguson WJ, Pivovarova E, Del Toro-Mejias L, Friedmann PD, Evans EA. Medication for opioid use disorder treatment continuity post-release from jail: a qualitative study with community-based treatment providers. Int J Drug Policy. 2022;110:103803.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"692_CR61","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1360-0443.1994.tb00879.x","volume":"89","author":"JR Caplehorn","year":"1994","unstructured":"Caplehorn JR, DALTON MSY, Cluff MC, PETRENAS AM. Retention in methadone maintenance and heroin addicts\u2019 risk of death. Addiction. 1994;89(2):203\u20137.","journal-title":"Addiction"},{"issue":"4","key":"692_CR62","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11606-015-3547-4","volume":"31","author":"N-P Luu","year":"2016","unstructured":"Luu N-P, Pitts S, Petty B, Sawyer MD, Dennison-Himmelfarb C, Boonyasai RT, Maruthur NM. Provider-to-provider communication during transitions of care from outpatient to acute care: a systematic review. J Gen Intern Med. 2016;31(4):417\u201325.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"692_CR63","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1186\/s12913-022-08023-0","volume":"22","author":"L Ljungholm","year":"2022","unstructured":"Ljungholm L, Edin-Liljegren A, Ekstedt M, Klinga C. What is needed for continuity of care and how can we achieve it?\u2013Perceptions among multiprofessionals on the chronic care trajectory. BMC Health Serv Res. 2022;22(1):686.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"692_CR64","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/hex.12435","volume":"19","author":"A Sweeney","year":"2016","unstructured":"Sweeney A, Davies J, McLaren S, Whittock M, Lemma F, Belling R, et al. Defining continuity of care from the perspectives of mental health service users and professionals: an exploratory, comparative study. Health Expect. 2016;19(4):973\u201387.","journal-title":"Health Expect"},{"issue":"2","key":"692_CR65","first-page":"72","volume":"1","author":"J Golzar","year":"2022","unstructured":"Golzar J, Noor S, Tajik O. Convenience sampling. Int J Educ Lang Stud. 2022;1(2):72\u20137.","journal-title":"Int J Educ Lang Stud"},{"issue":"4","key":"692_CR66","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/emermed-2021-211390","volume":"39","author":"T Lines","year":"2022","unstructured":"Lines T, Burdick C, Dewez X, Aldridge E, Neal-Williams T, Walker K, et al. Nature and extent of selection bias resulting from convenience sampling in the emergency department. Emerg Med J. 2022;39(4):325\u201330.","journal-title":"Emerg Med J"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-026-00692-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-026-00692-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-026-00692-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:02:56Z","timestamp":1790251376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13722-026-00692-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["692"],"URL":"https:\/\/doi.org\/10.1186\/s13722-026-00692-0","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Johns Hopkins Medicine IRB #5 (IRB00421590). All participants provided informed consent verbally.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"68"}}